<DOC>
	<DOCNO>NCT02332148</DOCNO>
	<brief_summary>3VM1001 topical cream may useful treatment chronic osteoarthritis knee . This proof concept study randomize , placebo-controlled , double-blind study compare treatment 3VM1001 cream inactive cream placebo . Subjects self-treat 30 day .</brief_summary>
	<brief_title>Assessment Safety Efficacy 3VM1001 Cream Treatment Chronic Pain Caused Knee Osteoarthritis .</brief_title>
	<detailed_description>3VM1001 topical cream may useful treatment chronic osteoarthritis knee . This proof concept study randomize , placebo-controlled , double-blind study compare treatment 3VM1001 cream inactive cream placebo . Subjects self-treat 30 day investigational drug placebo . Rescue medication acetaminophen , 2g daily , permit . This study intend evaluate safety efficacy 3VM1001 topical cream , copper-containing cream . Subjects self treat drug placebo three time daily 30 day . All subject total three visit clinic complete daily diary day 30 day treatment .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<criteria>Osteoarthritis knee accord American College Rheumatology clinical radiological criterion ; OA knee ≥ 6 month prior screen ; age 40 year old ; subject childbearing potential partner must use effective contraception ; woman childbearing age must negative pregnancy test screen use acceptable form birth control ; moderate severe chronic OA pain define POM score 40 mm 90 mm ; baseline WOMAC pain subscale score ≥ 9 ; change physical activity and/or therapy past 3 month ; concurrent medication take reason stable 14 day ; ability follow protocol reference cognitive situational factor ( eg . stable housing , ability attend visit ; ability read write English ; ability apply cream without assistance ; able provide write informed consent . Presence significant medical disorder would compromise participant 's safety take part trial ( e.g . cancer , immunosuppressed ) evidence alcohol substance abuse ; Wilson 's disease disorder copper metabolism BMI &gt; 35 Known hypersensitivity allergy component product , acetaminophen Pregnant breastfeed woman Transcutaneous electrical nerve stimulation use crutch , walker , wheel chair exclude prior treatment Active condition area treat eczema psoriasis , compromise integrity intact , superficial skin layer area treat . Pain joint index joint could interfere patient 's assessment pain index joint Recent injury ( traumatic sport relate ) either knee causing pain interference daily activity ( e.g . walking ) Recent surgery/procedure either knee causing pain could interfere study assessment pain , function , QoL . Extreme pain target knee characterize POM score &gt; 90 mm Mild pain target knee , characterize POM score &lt; 40 mm Open surgery target knee within last year Arthroscopic surgery target knee within last 3 month Use prohibit concomitant medications/therapies 30day treatment period include : 1. device therapeutic treatment knee pain ambulation 2. analgesic acetaminophen 3 . Systemic corticosteroid 4. investigational drug 5. chemotherapeutic drug 6. immunotherapy 7. topical product apply target knee</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>